Can Lab-Grown tumor models predict the best therapy for each patient?
NCT ID NCT05844865
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This pilot study aims to create personalized, lab-grown models of tumors from patients with gastrointestinal peritoneal carcinomatosis. Researchers will collect blood, ascites fluid, and tumor samples during planned surgeries to build vascularized micro-tumors. These models could help test how well different treatments work for each individual, potentially guiding more effective therapy choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biospecimen collection (blood, ascites/peritoneal wash fluid, and tumor samples) during planned surgery
- What this could lead to
- If successful, this could lead to personalized lab-grown tumor models that help predict which treatments work best for individual patients with gastrointestinal peritoneal carcinomatosis.
- What could go wrong
- This is a small pilot study focused on building models, not treating patients. The models may not perfectly mimic real tumors, and results may not translate to clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Chao Family Comprehensive Cancer Center, University of California, Irvine
RECRUITINGOrange, California, 92868, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple chemo cocktail aims to clear deadly bowel blockages in advanced stomach cancer
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New drug combo aims to tackle Chemotherapy-Resistant colorectal cancer in the abdomen
- Light-Activated therapy shows promise for tumor control without surgery
- Cancer-Fighting virus shows promise in Hard-to-Treat ovarian cancer
- New radiation technique targets stomach and ovarian cancer spread without surgery